semaglutide cardiovascular indication Wegovy® receives FDA approval for risk reduction in adults Semaglutide in Cardiometabolic Diseases: SELECTing

Yes, Wegovy (semaglutide 2.4 mg) can cause headaches as a recognised adverse effect

Wegovy Savings Card (For Insured Patients) For patients with commercial insurance that covers Wegovy, the savings card can reduce out-of-pocket costs to as little as $0 per month

The levers of health are interconnected, and when we pull one without understanding the others, we risk upsetting the delicate balance our bodies work so hard to maintain

In addition to taking Semaglutide or Tirzepatide, modifications to what you eat, how you exercise, your sleep routine, and your emotional health can improve your overall health and help maintain weight loss

Preparing for the Conversation Before meeting with your doctor, take time to gather information about your symptoms

[DOI] [PubMed] [Google Scholar] 135.Gaspari T, Liu H, Welungoda I, et al